UBS Group’s Mainz Biomed MYNZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.8K | Buy |
9,808
+7,897
| +413% | +$11.1K | ﹤0.01% | 7367 |
|
|
2025
Q1 | $6.13K | Sell |
1,911
-1,851
| -49% | -$5.94K | ﹤0.01% | 7614 |
|
|
2024
Q4 | $16.3K | Buy |
+3,762
| New | +$16.3K | ﹤0.01% | 6777 |
|
|
2024
Q2 | – | Sell |
-80
| Closed | -$3.3K | – | 8629 |
|
|
2024
Q1 | $3.3K | Buy |
+80
| New | +$3.3K | ﹤0.01% | 6577 |
|
|
2023
Q4 | – | Sell |
-2
| Closed | -$286 | – | 8392 |
|
|
2023
Q3 | $286 | Sell |
2
-21
| -91% | -$3K | ﹤0.01% | 7469 |
|
|
2023
Q2 | $4.45K | Sell |
23
-32
| -58% | -$6.19K | ﹤0.01% | 6451 |
|
|
2023
Q1 | $13.8K | Sell |
55
-1
| -2% | -$252 | ﹤0.01% | 6287 |
|
|
2022
Q4 | $15.8K | Buy |
+56
| New | +$15.8K | ﹤0.01% | 6768 |
|
|
2022
Q3 | – | Sell |
-34
| Closed | -$13K | – | 9510 |
|
|
2022
Q2 | $13K | Sell |
34
-2
| -6% | -$765 | ﹤0.01% | 6486 |
|
|
2022
Q1 | $21K | Sell |
36
-182
| -83% | -$106K | ﹤0.01% | 6354 |
|
|
2021
Q4 | $90K | Buy |
+218
| New | +$90K | ﹤0.01% | 5331 |
|